Q2 Solutions Q2 Solutions Actionable Insights for Better Health and Lab Solutions

12th Annual Biomarker Congress

Join Q2 Solutions at this year’s event and attend our podium presentation 

February 21, 2017 - February 22, 2017 | 08:00 - 17:00 Add to Calendar
Schedule a Meeting

About This Event

The 12th Annual Biomarker Congress brings together over 250 delegates representing leading biotech companies, global pharma organizations and internationally renowned academic institutions.  This year’s event will feature over 55 presentations, case studies, round-table and panel discussions focused on the key innovations of biomarker research in discovery and development, companion diagnostics, data management, innovative biology, precision medicine and clinical biomarkers.

Title: Pivotal Role of Clinical Trial Laboratories in Immuno-oncology drug development
Speaker: Radha Krishnan, MD, Chief Pathologist and Senior Medical Director
Date and Time: February 21, 2017 at 11:50am
Abstract: Laboratory capabilities required by immuno-oncology clinical development programs including case studies on effective laboratory services partnership models for immuno-oncology development

Join Q2 Solutions at this year’s Annual Biomarker Congress and learn more about some of our unique biomarker and companion diagnostic services. 

We look forward to meeting you in Manchester, UK.

Register for Event


Radha Krishnan, MD
Anatomic Pathology

Radha Krishnan, M.D., is chief pathologist at Q2 Solutions, a Quintiles Quest Joint Venture. In this role, and in collaboration with the company’s chief scientific officer and chief operating officer, Dr. Krishnan defines the plan for global Anatomic Pathology (AP) service offerings, including instrumentation, technician and pathologists. Additionally, she serves as the scientific advisor for AP services, such as immunohistochemistry (IHC), In-Situ Hybridization (ISH) hematopathology and cytology. This includes the supervision of all assay validation, Pathologist and staff training, proficiency testing, the review and approval of related SOPs, and validations to ensure global harmonization of AP laboratory testing in accordance with applicable regulations governing clinical laboratories.

Dr. Krishnan has more than 22 years of post-specialization experience, with the last seven years in senior leadership roles within Quintiles and Q2 Solutions, including the senior medical director and head of AP for Europe and Asia. Prior to Quintiles, Dr. Krishnan worked as a consultant Pathologist in tertiary referral hospitals and cancer centers and specialized in tumour pathology.   Dr. Krishnan has also been in the academia as an Associate professor in Pathology in the Faculty of Medicine at the University Technology MARA in Malaysia, and a lecturer in Pathology at the International Medical University in Kuala Lumpur.

Dr. Krishnan obtained her Bachelor of Medicine, Bachelor of Surgery (M.B.B.S) and her Doctorate in Medicine (M.D., Pathology) from the University of Madras in India. She is also a Member of the International Academy of Cytology (MIAC).

Updated as of September 2018.